Bedrosian Camille L - Insider Non-Derivative Transactions at Amylyx Pharmaceuticals, Inc. (AMLX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 1, 2025, Bedrosian Camille L's relationship to Amylyx Pharmaceuticals, Inc. (AMLX) is Officer (Chief Medical Officer), and currently has 175,756 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other AMLX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Bedrosian Camille L - Insider Non-Derivative Transactions of AMLX Common Stock

Bedrosian Camille L - Insider Non-Derivative Transactions at AMLX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 2, 2025	Sell -- (Common Stock)	6580	14.35	175756
Oct 1, 2025	Sell -- (Common Stock)	12039	14.58	182336
Apr 1, 2025	Sell -- (Common Stock)	12425	3.47	194375
Mar 7, 2025	Acquisition -- (Common Stock)	68420	0	206800
Dec 3, 2024	Sell -- (Common Stock)	5421	5.54	138380
Oct 1, 2024	Sell -- (Common Stock)	11442	3.2	143801
Apr 17, 2024	Acquisition -- (Common Stock)	96910	0	155243
Nov 28, 2023	Acquisition -- (Common Stock)	58333	0	58333